Page 2 - Zai Lab News Today

Baron Funds, an investment management company, released its “Baron Emerging Markets Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here.

SHANGHAI, May 23, 2024 /PRNewswire/ -- Qiming Venture Partners, a global-leading venture capital firm, is pleased to announce the promotion of Alex Zhou to Managing Partner. As a Qiming

Drug-resistant Acinetobacter baumannii is a growing global health threat and high priority pathogen needing new antibiotics, according to World Health Organization China NMPA approval based on...

Zai Lab Ltd. (ZLAB) and Innoviva Specialty Therapeutics announced Monday that China's National Medical Products Administration or NMPA has approved Zai Lab's New Drug Application for XACDURO (sulbactam-durlobactam) to treat hospital-acquired and ventilator-associated pneumonia caused by Acinetobacter baumannii-calcoaceticus complex in China.

The NMPA's decision was based on the positive outcomes of the Phase III ATTACK trial.

If trained on buildings, the model could generate geometrically rigorous creative designs and inspire a new generation of buildings and architects.

On March 13, 2024, Utah Governor Spencer Cox signed into law the Utah Artificial Intelligence Policy Act ("UAIPA"), which took effect May 1, 2024.

BlackRock's COO discussed the firm's GenAI and ChatGPT learnings in a recent interview.

Baader Bank Aktiengesellschaft acquired a new stake in Zai Lab Limited (NASDAQ:ZLAB – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 9,284 shares of the company’s stock, valued at approximately $253,000. A number of other large investors have also added […]

Despite its status as a leading light of the 1980s AI revolution and being home to two of the top universities in the country - MIT and Harvard - Boston is struggling to retain top tech talent.